XML 52 R43.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Litigation, regulatory and similar matters (Tables)
 6 Months Ended
Jun. 30, 2024
Notes Litigation Regulatory And Similar Matters [Line Items]  
Disclosure of provisions for litigation, regulatory and similar matters [text block]
 
 
 
 
 
 
 
 
 
 
Provisions for litigation, regulatory and similar matters,
 
by business division and in Group Items
1
USD m
Global Wealth
Management
Personal &
Corporate
Banking
 
Asset
Management
Investment
Bank
Non-core
and Legacy
Group Items
UBS Group
Balance as of 31 December 2023
1,235
157
15
294
2,186
134
4,020
Balance as of 31 March 2024
1,201
152
2
288
2,142
134
3,920
Increase in provisions recognized in the income statement
28
0
0
6
0
3
37
Release of provisions recognized in the income statement
(11)
0
0
(7)
(22)
0
(41)
Reclassification of IFRS 3 contingent liabilities to IAS 37 provisions
2
0
0
0
0
1,171
0
1,171
Provisions used in conformity with designated purpose
2
(10)
0
0
(5)
(1,425)
(1)
(1,442)
Foreign currency translation and other movements
(8)
(1)
0
(1)
(4)
0
(15)
Balance as of 30 June 2024
1,199
152
2
280
1,862
135
3,630
1 Provisions, if any,
 
for the matters
 
described in items 2
 
and 10 of this
 
Note are recorded
 
in Global Wealth
 
Management. Provisions,
 
if any, for
 
the matters described
 
in items 5, 6,
 
7, 8, 9 and
 
11 of this Note
 
are
recorded in Non-core and Legacy. Provisions, if any, for the matters described
 
in items 13 and 14 of
 
this Note are recorded in Group Items. Provisions, if any, for the matters
 
described in item 1 of this
 
Note are allocated
between Global Wealth Management,
 
Personal & Corporate
 
Banking and Non-core and
 
Legacy. Provisions,
 
if any, for
 
the matters described in item
 
3 of this Note are
 
allocated between the Investment Bank,
 
Non-
core and Legacy and Group Items.
 
Provisions, if any,
 
for the matters described in item 4 of
 
this Note are allocated between Global
 
Wealth Management and Personal
 
& Corporate Banking. Provisions,
 
if any, for the
matters described in item 12 of this Note are allocated between the Investment
 
Bank and Non-core and Legacy.
 
2 During the second quarter of 2024, UBS agreed to fund an offer
 
by the Credit Suisse supply chain
finance funds to
 
redeem all of
 
the outstanding units
 
of the respective
 
funds. As
 
a result, UBS
 
reclassified USD
944
m from IFRS
 
3 acquisition-related contingent
 
liabilities to IAS
 
37 provisions related
 
to litigation,
regulatory and similar matters, as the
 
probability of an outflow of resources increased,
 
bringing the total IAS 37 provision for
 
this matter to USD
1,421
m, with no impact on the income
 
statement. The provision has
been used to recognize the funding obligation, which was accounted for as a derivative liability with a fair value
 
of USD
1,421
m as of 30 June 2024.